Cargando…
Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) has a significant clinical relevance of being associated with a shorter median time to relapse and death and does not respond to endocrine therapy or other available targeted agents. Increased aggressiveness of this tumor, as well as resistance to standard drug t...
Autores principales: | Collina, Francesca, Di Bonito, Maurizio, Li Bergolis, Valeria, De Laurentiis, Michelino, Vitagliano, Carlo, Cerrone, Margherita, Nuzzo, Francesco, Cantile, Monica, Botti, Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609334/ https://www.ncbi.nlm.nih.gov/pubmed/26504780 http://dx.doi.org/10.1155/2015/158682 |
Ejemplares similares
-
Long Non-Coding RNA HOTAIR in Breast Cancer Therapy
por: Cantile, Monica, et al.
Publicado: (2020) -
LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of Triple Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2019) -
Overexpression of Cell Cycle Progression Inhibitor Geminin is Associated with Tumor Stem-Like Phenotype of Triple-Negative Breast Cancer
por: Di Bonito, Maurizio, et al.
Publicado: (2012) -
Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients
por: Botti, Gerardo, et al.
Publicado: (2017) -
Morphological and pathological features of basal-like breast cancer
por: Botti, Gerardo, et al.
Publicado: (2019)